New Podcast Feature: Dr. Geoffrey Young on SurgOnc Today
-
By
-
August 28, 2026
-
1 min
By
August 28, 2026
Ocular tumor coding can be challenging because ocular oncology often involves evolving lesions, diagnostic uncertainty, and terminology that does not always translate cleanly into ICD-10-CM codes. Understanding how to distinguish benign, malignant, in situ, and uncertain histologic behavior neoplasms is essential for accurate coding, medical necessity, and audit defensibility.
September 1, 2026
Liquid biopsy and molecular profiling are expanding the diagnostic and prognostic role of genetic testing in retinoblastoma.
September 1, 2026